Interferon-α2b Treatment for COVID-19

The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China. In this uncontrolled, exploratory study, 77 adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiong, Chen, Virginia, Shannon, Casey P., Wei, Xiao-Shan, Xiang, Xuan, Wang, Xu, Wang, Zi-Hao, Tebbutt, Scott J., Kollmann, Tobias R., Fish, Eleanor N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242746/
https://www.ncbi.nlm.nih.gov/pubmed/32574262
http://dx.doi.org/10.3389/fimmu.2020.01061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242746/
https://www.ncbi.nlm.nih.gov/pubmed/32574262
http://dx.doi.org/10.3389/fimmu.2020.01061

Ejemplares similares